SOOIL Diabecare RS/AnyDana-i/AnyDana-A up to 2.x Bluetooth LE privileges management

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
5.1$0-$5k0.00

Summaryinfo

A vulnerability was found in SOOIL Diabecare RS, AnyDana-i and AnyDana-A up to 2.x. It has been classified as problematic. The impacted element is an unknown function of the component Bluetooth LE Handler. The manipulation leads to an unknown weakness. This vulnerability is documented as CVE-2020-27268. The attack requires being on the local network. There is not any exploit available. Upgrading the affected component is recommended.

Detailsinfo

A vulnerability, which was classified as problematic, has been found in SOOIL Diabecare RS, AnyDana-i and AnyDana-A up to 2.x. This issue affects an unknown code block of the component Bluetooth LE Handler. Using CWE to declare the problem leads to CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. Impacted is confidentiality.

The weakness was released 01/20/2021 as icsma-21-012-01. It is possible to read the advisory at us-cert.cisa.gov. The identification of this vulnerability is CVE-2020-27268. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1068 according to MITRE ATT&CK.

Upgrading to version 3.0 eliminates this vulnerability.

Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.

Productinfo

Type

Vendor

Name

Version

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 5.4
VulDB Meta Temp Score: 5.3

VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍

NVD Base Score: 6.5
NVD Vector: 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

NVD Base Score: 🔍

Exploitinginfo

Class: Privileges management
CWE: CWE-269 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Partially

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: Upgrade
Status: 🔍

0-Day Time: 🔍

Upgrade: Diabecare RS/AnyDana-i/AnyDana-A 3.0

Timelineinfo

10/19/2020 🔍
01/20/2021 +93 days 🔍
01/20/2021 +0 days 🔍
02/15/2021 +26 days 🔍

Sourcesinfo

Advisory: icsma-21-012-01
Status: Confirmed

CVE: CVE-2020-27268 (🔍)
GCVE (CVE): GCVE-0-2020-27268
GCVE (VulDB): GCVE-100-168131

Entryinfo

Created: 01/20/2021 08:18
Updated: 02/15/2021 15:51
Changes: 01/20/2021 08:18 (37), 02/15/2021 15:45 (5), 02/15/2021 15:51 (20)
Complete: 🔍
Cache ID: 216::103

Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Might our Artificial Intelligence support you?

Check our Alexa App!